South Africa’s Adcock Says To Fall Into 9-month Loss – Yahoo News

US Ebola Patients ‘Improve Dramatically’ From Experimental Serum | Video – ABC News

REUTERS/Siphiwe Sibeko JOHANNESBURG (Reuters) – South Africa’s No.2 drugmaker Adcock Ingram will post a loss in the first nine-months of its fiscal year, it said on Tuesday, a sign a turnaround plan led by top investor Bidvest is yet to gain traction. Adcock is lagging behind rivals as it grapples with slowing sales, over-reliance on a heavily regulated home market and poor distribution network. Industrial conglomerate Bidvest, which owns about 34 percent of Adcock, has been pushing through changes after blocking a $1.2 billion takeover bid of Adcock from Chile’s CFR Pharmaceuticals earlier this year. “The effects of the corrective action are unlikely to yield significant improvement in the short term,” Adcock said in a trading statement. “The board, however, remains optimistic about the company’s long term prospects.” Adcock Chief Executive Kevin Wakeford, appointed weeks after CFR dropped the bid in February, is reorganising the company to match the decentralised model of Bidvest in a bid to make the different units more nimble and increase accountability.

The Centers for Disease Control takes that as a moment of education they say transmitting people it is really hard no casual contact it’s not airborne. It has to be transmitted through bodily fluids. And so the CDC says.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s